Finzati - Logo
CMND logo

Clearmind Medicine Inc.

CMND • Biotechnology
$6.12
▲ +0.12 (+2.00%)
Current price
EarningsLatest report: Apr 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.85M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak profitability
Financial data as of: Apr 30, 2026, 12:00 AM UTCLast earnings update: Apr 30, 2026, 12:00 AM UTCLast profile update: Sep 11, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$6.12
Change2.00%
Shares Out301.96K
Market Cap$1.85M
Enterprise Value$-11.75M
52W Range0.92 - 524.00
Beta-1.22
P/E-0.23
P/B0.16
P/FCF-0.26
EV/EBITDA1.64
EV/FCF1.64

Investment DNA

How strong this company looks for long-term investors

31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
51/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 11/15/2022
Industry: Biotechnology
P/B i: 0.16
Debt / Equity i: 1.49
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score10 / 20
Debt / Equity: 1.49
Current Ratio: 1.22
Quick Ratio: 1.22
Status: Moderate

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
HRT FINANCIAL LP
Transaction: 06/16/2026
SELL
Change
-22,139
Price
$3.31
Filing
06/18/2026
Type
SELL
HRT FINANCIAL LP
Transaction: 06/15/2026
SELL
Change
-3,183
Price
$3.32
Filing
06/17/2026
Type
SELL
HRT FINANCIAL LP
Transaction: 06/12/2026
SELL
Change
-2,102
Price
$3.36
Filing
06/16/2026
Type
SELL